Compagnie Lombard Odier SCmA’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXP
Compagnie Lombard Odier SCmA's SLXP Position: Q2 2015 in Review
Compagnie Lombard Odier SCmA sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 260 shares — an estimated $45K sold.
Compagnie Lombard Odier SCmA first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $45K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.
- Compagnie Lombard Odier SCmA reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
- Compagnie Lombard Odier SCmA sold 260 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $45K.
- Compagnie Lombard Odier SCmA first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
- Compagnie Lombard Odier SCmA's SALIX PHARMACEUTICALS LTD DEL position peaked at $45K in Q1 2015.
- 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2015, filed 14 Aug 2015.